Heiner Dreismann

Heiner Dreismann discloses dealings in 2 companies, chiefly Nanogen Inc and Interpace Biosciences, Inc. Over a trading history stretching from 27 October 2006 to 3 June 2015, the count stands at 6 filings.

Every open-market trade on record is a sale: 1 sale worth €12k. Outside the open market, there are 5 share grants.

The latest filing, published on 4 June 2015, reports a share grant of €40k in Interpace Biosciences, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.